Lifestance Health Group Inc
NASDAQ:LFST
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
4.81
8.71
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Lifestance Health Group Inc
Lifestance Health Group Inc
Cash & Cash Equivalents
Lifestance Health Group Inc
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Lifestance Health Group Inc
NASDAQ:LFST
|
Cash & Cash Equivalents
$78.8m
|
CAGR 3-Years
61%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
DaVita Inc
NYSE:DVA
|
Cash & Cash Equivalents
$1.1B
|
CAGR 3-Years
1%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-3%
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Cash & Cash Equivalents
$764m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
12%
|
CAGR 10-Years
16%
|
|
|
CVS Health Corp
NYSE:CVS
|
Cash & Cash Equivalents
$6.9B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
6%
|
CAGR 10-Years
20%
|
|
|
Cigna Corp
NYSE:CI
|
Cash & Cash Equivalents
$5.9B
|
CAGR 3-Years
19%
|
CAGR 5-Years
5%
|
CAGR 10-Years
14%
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Cash & Cash Equivalents
$1.5B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
33%
|
CAGR 10-Years
10%
|
|
Lifestance Health Group Inc
Glance View
Lifestance Health Group, Inc. operates a holding company. The company is headquartered in Scottsdale, Arizona and currently employs 6,635 full-time employees. The company went IPO on 2021-06-10. The firm is focused on providing evidence-based, medically driven treatment services for children, adolescents, and adults suffering from a variety of mental health issues in an outpatient care setting, both in-person and through its digital health telemedicine offering. The firm's clinicians offer patients a range of mental health services, including psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family and group therapy. Its patient-focused platform combines differentiated clinical capabilities with a personalized, digitally powered patient experience designed to improve patient access and treatment. The company treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders and post-traumatic stress disorder. The company operates approximately 534 centers and employs over 4,800 clinicians across the United States.
See Also
What is Lifestance Health Group Inc's Cash & Cash Equivalents?
Cash & Cash Equivalents
78.8m
USD
Based on the financial report for Dec 31, 2023, Lifestance Health Group Inc's Cash & Cash Equivalents amounts to 78.8m USD.
What is Lifestance Health Group Inc's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 3Y
61%
Over the last year, the Cash & Cash Equivalents growth was -27%. The average annual Cash & Cash Equivalents growth rates for Lifestance Health Group Inc have been 61% over the past three years .
You don't have any saved screeners yet
